Effect of Rabbit Anti-Thymocyte Globulin Induction Therapy on the Incidence of Acute Cellular Rejection and Infection Complications After Lung Transplantation

J Havlin,L Valentova-Bartakova,T Dousova,D Paugsch,J Kolarik,J Simonek,R Lischke,M Svorcova,J Pozniak

doi:10.1016/j.healun.2018.01.1183

Effect of Rabbit Anti-Thymocyte Globulin Induction Therapy on the Incidence of Acute Cellular Rejection and Infection Complications After Lung Transplantation

J Havlin, L Valentova-Bartakova + Show 7 more

https://doi.org/10.1016/j.healun.2018.01.1183

Copy DOI

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation	Publication Date: Apr 1, 2018
Citations: 1

Affiliation: University Hospital in Motol

#Incidence Of Acute Cellular Rejection #Rabbit Anti-Thymocyte Globulin Induction Therapy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Anti-thymocyte globulin (ATG) induction therapy is supposed to reduce the incidence of acute cellular rejection (ACR), which is associated with inferior outcomes in lung transplantation (LTx). However, according to the different types and dosage of ATG, there is no consensus on its efficacy and safety. The aim of this study was to evaluate the effect of rabbit ATG induction on the incidence of ACR and infection complications during the first year after LTx.

Full Text